BioSupply Trends Quarterly logo
Subscribe
Winter 2014 - Plasma
  Download Issue
Share

Up Front

Features

The Physician’s Role in Immune Globulin Reimbursement

Update on Rheumatoid Arthritis

BioSupply Trends Quarterly Winter 2014 Plasma Therapies

Immune Globulin: Each Product Is Unique

A Review of Coagulation Factor Disorders

Breaking the Cancer Code

BioTrends Watch

Washington Report
Young Adults Needed to Make Health Law Successful
FDA Awards Seven Grants to Stimulate Pediatric Medical Device Innovation
CMS Makes Final Decision on PET Scan Coverage
Track-and-Trace, Compounding Reform Bill Signed Into Law
"Champions" Help Consumers Understand New Insurance Marketplace
Industry News
New CMS and ACA Deadlines in 2014 for Physicians
Climates Associated with Seasonal Flu Epidemics
Vaccine Update
Registry Launched for Hemophilia A Patients
FDA Approves Obinutuzumab for CLL
People and Places in the News - January 2014
Potential Chagas Vaccine Candidate Shows Efficacy
Immune System Therapy Shows Promise in Adults with Leukemia
AARDA Creates Public Service Campaign for AD Patients
Study Shows Protective Properties of Flu Vaccines
More than Half of Healthcare Providers Now Write Electronic Prescriptions
New Method Developed for Forecasting Flu Outbreaks
Universal Flu Vaccine Effective in Animals
Menactra Vaccine May Be Safe During Pregnancy
Potential Vaccine Could Be Effective in Newborns After Birth
Fluzone High-Dose More Effective Than Standard Dose in Older Adults

BioFocus

Industry Insight
Thirty Years On, IVIG Clinical Research Keeps Rolling
By Keith Berman, MPH, MBA
Patient Profile
Fibromyalgia: A Patient's Perspective
By Trudie Mitschang
Physician Profile
Fibromyalgia: A Physician's Perspective
By Trudie Mitschang
Leading the Way with Lifesaving Innovation
By Trudie Mitschang

BioSources

BioResearch
IVIG in Combination with Corticosteroids Reduces Morbidity and Mortality in Toxic Epidermal Necrolysis
Dermatomyositis with Isolated Severe Skin Lesions Responds to IVIG Therapy
Influenza Vaccination Associated with Reduced Risk of Major Adverse Cardiovascular Events: Meta-Analysis